Dow Up 1.64% Nasdaq Up 1.86%

ProPhase Labs, Inc. (PRPH)

-NasdaqCM
1.38 Up 0.04(2.99%) Jun 29, 3:58PM EDT
Prev Close:1.34
Open:1.35
Bid:1.30 x 100
Ask:2.90 x 500
1y Target Est:15.55
Beta:-0.06572
Earnings Date:Aug 10 - Aug 15 (Est.)
Day's Range:1.35 - 1.40
52wk Range:1.05 - 1.85
Volume:3,121
Avg Vol (3m):10,619
Market Cap:23.57M
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PRPH

Comparison

Symbol% ChgMkt Cap
PRPHUp 2.99%23.57M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ProPhase Labs, Inc. manufactures, markets, and distributes a range of homeopathic and health care products to general public in the United States. It also engages in the research and development of over-the-counter drugs and natural base health pr... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback